INTUITIVE SURGICAL INC (1ISRG.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:1ISRG - US46120E6023 - Common Stock
461.35 EUR
+60.75 (+15.16%)
Taking everything into account, 1ISRG scores 6 out of 10 in our fundamental rating. 1ISRG was compared to 63 industry peers in the Health Care Equipment & Supplies industry. 1ISRG has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. 1ISRG shows excellent growth, but is valued quite expensive already. These ratings would make 1ISRG suitable for growth and quality investing!
1. Profitability
1.1 Basic Checks
In the past year 1ISRG was profitable.
In the past year 1ISRG had a positive cash flow from operations.
In the past 5 years 1ISRG has always been profitable.
Each year in the past 5 years 1ISRG had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 14.19%, 1ISRG belongs to the top of the industry, outperforming 91.67% of the companies in the same industry.
The Return On Equity of 1ISRG (16.12%) is better than 81.67% of its industry peers.
With an excellent Return On Invested Capital value of 12.45%, 1ISRG belongs to the best of the industry, outperforming 88.33% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for 1ISRG is in line with the industry average of 9.81%.
The 3 year average ROIC (10.15%) for 1ISRG is below the current ROIC(12.45%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.19% | ||
| ROE | 16.12% | ||
| ROIC | 12.45% |
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.21%
ROE(5y)12.97%
ROIC(3y)10.15%
ROIC(5y)9.87%
1.3 Margins
1ISRG's Profit Margin of 28.58% is amongst the best of the industry. 1ISRG outperforms 96.67% of its industry peers.
In the last couple of years the Profit Margin of 1ISRG has declined.
With an excellent Operating Margin value of 29.44%, 1ISRG belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Operating Margin of 1ISRG has declined.
1ISRG has a better Gross Margin (66.38%) than 75.00% of its industry peers.
1ISRG's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 29.44% | ||
| PM (TTM) | 28.58% | ||
| GM | 66.38% |
OM growth 3Y-4.19%
OM growth 5Y-1.68%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), 1ISRG is creating some value.
The number of shares outstanding for 1ISRG has been increased compared to 1 year ago.
The number of shares outstanding for 1ISRG has been increased compared to 5 years ago.
1ISRG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
There is no outstanding debt for 1ISRG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | N/A |
ROIC/WACC1.42
WACC8.75%
2.3 Liquidity
1ISRG has a Current Ratio of 4.97. This indicates that 1ISRG is financially healthy and has no problem in meeting its short term obligations.
1ISRG's Current ratio of 4.97 is amongst the best of the industry. 1ISRG outperforms 96.67% of its industry peers.
A Quick Ratio of 4.20 indicates that 1ISRG has no problem at all paying its short term obligations.
The Quick ratio of 1ISRG (4.20) is better than 96.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.97 | ||
| Quick Ratio | 4.2 |
3. Growth
3.1 Past
1ISRG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 28.12%, which is quite impressive.
Measured over the past years, 1ISRG shows a quite strong growth in Earnings Per Share. The EPS has been growing by 11.48% on average per year.
The Revenue has grown by 22.18% in the past year. This is a very strong growth!
1ISRG shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.27% yearly.
EPS 1Y (TTM)28.12%
EPS 3Y13.83%
EPS 5Y11.48%
EPS Q2Q%30.43%
Revenue 1Y (TTM)22.18%
Revenue growth 3Y13.51%
Revenue growth 5Y13.27%
Sales Q2Q%22.91%
3.2 Future
Based on estimates for the next years, 1ISRG will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.47% on average per year.
The Revenue is expected to grow by 14.12% on average over the next years. This is quite good.
EPS Next Y19.93%
EPS Next 2Y16.17%
EPS Next 3Y15.85%
EPS Next 5Y15.47%
Revenue Next Year21.17%
Revenue Next 2Y18.1%
Revenue Next 3Y16.53%
Revenue Next 5Y14.12%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
1ISRG is valuated quite expensively with a Price/Earnings ratio of 61.93.
1ISRG's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of 1ISRG to the average of the S&P500 Index (26.54), we can say 1ISRG is valued expensively.
Based on the Price/Forward Earnings ratio of 53.92, the valuation of 1ISRG can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of 1ISRG indicates a slightly more expensive valuation: 1ISRG is more expensive than 63.33% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.78, 1ISRG is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 61.93 | ||
| Fwd PE | 53.92 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, 1ISRG is valued a bit more expensive than 63.33% of the companies in the same industry.
1ISRG's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 84.18 | ||
| EV/EBITDA | 52.99 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 1ISRG does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of 1ISRG may justify a higher PE ratio.
1ISRG's earnings are expected to grow with 15.85% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.11
PEG (5Y)5.39
EPS Next 2Y16.17%
EPS Next 3Y15.85%
5. Dividend
5.1 Amount
1ISRG does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
BIT:1ISRG (10/30/2025, 7:00:00 PM)
461.35
+60.75 (+15.16%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners88.66%
Inst Owner ChangeN/A
Ins Owners0.45%
Ins Owner ChangeN/A
Market Cap165.38B
Revenue(TTM)9.61B
Net Income(TTM)2.75B
Analysts78.54
Price Target521.28 (12.99%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.16%
Min EPS beat(2)11.61%
Max EPS beat(2)18.71%
EPS beat(4)4
Avg EPS beat(4)13.53%
Min EPS beat(4)3.05%
Max EPS beat(4)20.76%
EPS beat(8)8
Avg EPS beat(8)11%
EPS beat(12)11
Avg EPS beat(12)7.6%
EPS beat(16)13
Avg EPS beat(16)5.75%
Revenue beat(2)2
Avg Revenue beat(2)2%
Min Revenue beat(2)1.84%
Max Revenue beat(2)2.17%
Revenue beat(4)4
Avg Revenue beat(4)2.55%
Min Revenue beat(4)1.09%
Max Revenue beat(4)5.12%
Revenue beat(8)5
Avg Revenue beat(8)1.17%
Revenue beat(12)6
Avg Revenue beat(12)0.55%
Revenue beat(16)8
Avg Revenue beat(16)0.31%
PT rev (1m)1.55%
PT rev (3m)2.26%
EPS NQ rev (1m)3.15%
EPS NQ rev (3m)3.5%
EPS NY rev (1m)5.63%
EPS NY rev (3m)9.92%
Revenue NQ rev (1m)1.61%
Revenue NQ rev (3m)1.8%
Revenue NY rev (1m)1.17%
Revenue NY rev (3m)2.65%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 61.93 | ||
| Fwd PE | 53.92 | ||
| P/S | 19.89 | ||
| P/FCF | 84.18 | ||
| P/OCF | 64.58 | ||
| P/B | 11.22 | ||
| P/tB | 11.45 | ||
| EV/EBITDA | 52.99 |
EPS(TTM)7.45
EY1.61%
EPS(NY)8.56
Fwd EY1.85%
FCF(TTM)5.48
FCFY1.19%
OCF(TTM)7.14
OCFY1.55%
SpS23.19
BVpS41.12
TBVpS40.28
PEG (NY)3.11
PEG (5Y)5.39
Graham Number83.02
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.19% | ||
| ROE | 16.12% | ||
| ROCE | 16.61% | ||
| ROIC | 12.45% | ||
| ROICexc | 24.65% | ||
| ROICexgc | 25.69% | ||
| OM | 29.44% | ||
| PM (TTM) | 28.58% | ||
| GM | 66.38% | ||
| FCFM | 23.63% |
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.21%
ROE(5y)12.97%
ROIC(3y)10.15%
ROIC(5y)9.87%
ROICexc(3y)15.35%
ROICexc(5y)15.85%
ROICexgc(3y)16.06%
ROICexgc(5y)16.75%
ROCE(3y)13.54%
ROCE(5y)13.16%
ROICexgc growth 3Y-7.59%
ROICexgc growth 5Y-7%
ROICexc growth 3Y-6.87%
ROICexc growth 5Y-6.06%
OM growth 3Y-4.19%
OM growth 5Y-1.68%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
F-Score8
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 111.36% | ||
| Cap/Sales | 7.17% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 85.84% | ||
| Profit Quality | 82.69% | ||
| Current Ratio | 4.97 | ||
| Quick Ratio | 4.2 | ||
| Altman-Z | N/A |
F-Score8
WACC8.75%
ROIC/WACC1.42
Cap/Depr(3y)197.35%
Cap/Depr(5y)162.98%
Cap/Sales(3y)12.27%
Cap/Sales(5y)10.16%
Profit Quality(3y)56.77%
Profit Quality(5y)75.99%
High Growth Momentum
Growth
EPS 1Y (TTM)28.12%
EPS 3Y13.83%
EPS 5Y11.48%
EPS Q2Q%30.43%
EPS Next Y19.93%
EPS Next 2Y16.17%
EPS Next 3Y15.85%
EPS Next 5Y15.47%
Revenue 1Y (TTM)22.18%
Revenue growth 3Y13.51%
Revenue growth 5Y13.27%
Sales Q2Q%22.91%
Revenue Next Year21.17%
Revenue Next 2Y18.1%
Revenue Next 3Y16.53%
Revenue Next 5Y14.12%
EBIT growth 1Y36.82%
EBIT growth 3Y8.76%
EBIT growth 5Y11.37%
EBIT Next Year40.01%
EBIT Next 3Y23.66%
EBIT Next 5Y20.46%
FCF growth 1Y80.69%
FCF growth 3Y-9.1%
FCF growth 5Y2.14%
OCF growth 1Y46.32%
OCF growth 3Y4.95%
OCF growth 5Y8.61%
INTUITIVE SURGICAL INC / 1ISRG.MI FAQ
Can you provide the ChartMill fundamental rating for INTUITIVE SURGICAL INC?
ChartMill assigns a fundamental rating of 7 / 10 to 1ISRG.MI.
Can you provide the valuation status for INTUITIVE SURGICAL INC?
ChartMill assigns a valuation rating of 2 / 10 to INTUITIVE SURGICAL INC (1ISRG.MI). This can be considered as Overvalued.
Can you provide the profitability details for INTUITIVE SURGICAL INC?
INTUITIVE SURGICAL INC (1ISRG.MI) has a profitability rating of 8 / 10.
What are the PE and PB ratios of INTUITIVE SURGICAL INC (1ISRG.MI) stock?
The Price/Earnings (PE) ratio for INTUITIVE SURGICAL INC (1ISRG.MI) is 61.93 and the Price/Book (PB) ratio is 11.22.
What is the expected EPS growth for INTUITIVE SURGICAL INC (1ISRG.MI) stock?
The Earnings per Share (EPS) of INTUITIVE SURGICAL INC (1ISRG.MI) is expected to grow by 19.93% in the next year.